Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Combining Subtractive Genomics With Computer-Aided Drug Discovery Techniques to Effectively Target S. Sputigena in Periodontitis Publisher

Summary: Study identifies three unique proteins in S. sputigena for new periodontitis treatments, with cubebin showing promise as a multitargeting antibacterial agent. #Periodontitis #DrugDiscovery

Praveen M1 ; Sree CG2 ; Brogi S3, 4 ; Calderone V3 ; Dalei KPKP5
Authors

Source: Computation Published:2025


Abstract

This study aimed to provide an inclusive in silico investigation for the identification of novel drug targets that can be exploited to develop drug candidates for treating oral infections caused by S. sputigena. By coupling subtractive genomics with an in silico drug discovery approach, we identified dTDP-4-dehydrorhamnose 3,5-epimerase (UniProt ID: C9LUR0), UTP-glucose-1-phosphate uridyltransferase (UniProt ID: C9LRH1), and imidazole glycerol phosphate synthase (UniProt ID: C9LTU7) as three unique proteins crucial for the S. sputigena life cycle with no substantial similarity to human proteins. These potential drug targets served as the starting point for screening bioactive phytochemicals (1090 compounds) from the Indian Medicinal Plants, Phytochemistry and Therapeutics (IMPPAT) database. Among the screened natural products, cubebin (IMPHY001912) showed a higher affinity for two of the three selected targets, as evidenced by molecular docking and molecular dynamics studies. Given its favorable drug-like profile and possible multitargeting behavior, cubebin could be further exploited as an antibacterial agent for treating S. sputigena-mediated oral infections. It is worth nothing that cubebin could be the active ingredient of appropriate formulations such as mouthwash and/or toothpaste to treat S. sputigena-induced periodontitis, with the advantage of limiting the adverse effects that could affect the use of current drugs. © 2025 by the authors.
Related Docs
View other Related Docs
1. Discovery of Novel Hit Compounds As Potential Hdac1 Inhibitors: The Case of Ligand- and Structure-Based Virtual Screening, Computers in Biology and Medicine (2021)
2. Disruption of Irisin Dimerization by Fda-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes, International Journal of Molecular Sciences (2023)
3. In Silico Identification of Natural Products and World-Approved Drugs Targeting the Keap1/Nrf2 Pathway Endowed With Potential Antioxidant Profile, Computation (2023)
Experts (# of related papers)
View all Related Experts
Afshin Fassihi (3)
Lotfollah Saghaie Dehkordi (2)
Combining Subtractive Genomics With Computer-Aided Drug Discovery Techniques to Effectively Target S. Sputigena in Periodontitis
Other Related Docs
4. Preparing a Database of Corrected Protein Structures Important in Cell Signaling Pathways, Research in Pharmaceutical Sciences (2023)
5. Amyloid ß Fibril Disruption by Oleuropein Aglycone: Long-Time Molecular Dynamics Simulation to Gain Insight Into the Mechanism of Action of This Polyphenol From Extra Virgin Olive Oil, Food and Function (2020)
6. Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel Sars-Cov-2 Nsp3 Mac1 Domain Inhibitors, Viruses (2023)
7. Identification of Novel 3-Hydroxy-Pyran-4-One Derivatives As Potent Hiv-1 Integrase Inhibitors Using in Silico Structure-Based Combinatorial Library Design Approach, Frontiers in Chemistry (2019)
8. Pyrimido[4,5-B]Indole Derivatives Bearing 1,2,4-Oxadiazole Moiety As Mdm2 Inhibitor Candidates in Cancer Treatment, Future Medicinal Chemistry (2023)
9. Discovery of Novel Direct Small-Molecule Inhibitors Targeting Hif-2Α Using Structure-Based Virtual Screening, Molecular Dynamics Simulation, and Mm-Gbsa Calculations, Molecular Diversity (2024)
10. An Integrated in Silico Screening Strategy for Identifying Promising Disruptors of P53-Mdm2 Interaction, Computational Biology and Chemistry (2019)
11. Virtual Screening for the Identification of Potential Candidate Molecules Against Envelope (E) and Membrane (M) Proteins of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
12. Connection of Mir-185 and Mir-320A Expression Levels With Response to Interferon-Beta in Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2020)
13. Design, Synthesis, and Cytotoxicity Evaluation of Novel Indole-Acylhydrazone Derivatives of 4-Pyridinone As Potential Histone Deacetylase-2 Inhibitors, Research in Pharmaceutical Sciences (2022)
14. Proteomics to Metabolomics: A New Insight Into the Pathogenesis of Hypertensive Nephropathy, Kidney and Blood Pressure Research (2023)
15. The Analysis of a Time-Course Transcriptome Profile by Systems Biology Approaches Reveals Key Molecular Processes in Acute Kidney Injury, Journal of Research in Medical Sciences (2019)
16. Time-Series Bioinformatics Analysis of Sars-Cov-Infected Cells to Identify the Biological Processes Associated With Severe Acute Respiratory Syndrome, Human Antibodies (2024)
17. System Biology Analysis to Develop Diagnostic Biomarkers, Monitoring Pathological Indexes, and Novel Therapeutic Approaches for Immune Targeting Based on Maggot Bioactive Compounds and Polyphenolic Cocktails in Mice With Gastric Cancer, Environmental Research (2023)
18. Riboflavin and Histidine Metabolisms Are Two Key Pathways Related to the Clinically Isolated Syndrome (Cis): A Wgcna-Based in Silico Analysis, Current Pharmacogenomics and Personalized Medicine (2023)
19. Bioinformatic Screening of Compounds From Iranian Lamiaceae Family Members Against Sars-Cov-2 Spike Protein, Letters in Drug Design and Discovery (2023)
20. Exosomes As Efficient Platforms for Delivering Adenosine-Tetra Peptide Conjugate to Pancreatic Cancer Cells: An in Vitro/In Silico Study, Journal of Drug Delivery Science and Technology (2023)